(Q54587561)

English

Identification of a c-kit exon 8 internal tandem duplication in a feline mast cell tumor case and its favorable response to the tyrosine kinase inhibitor imatinib mesylate.

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/16908071

Identification of a c-kit exon 8 internal tandem duplication in a feline mast cell tumor case and its favorable response to the tyrosine kinase inhibitor imatinib mesylate. (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/16908071

0 references

1 reference

based on heuristic

inferred from title

author name string

Mayu Isotani

1

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/16908071

Kyoichi Tamura

2

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/16908071

Hiroko Yagihara

3

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/16908071

Michiko Hikosaka

4

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/16908071

Kenichiro Ono

5

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/16908071

Tsukimi Washizu

6

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/16908071

Makoto Bonkobara

7

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/16908071

publication date

5 September 2006

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/16908071

Veterinary Immunology and Immunopathology

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/16908071

114

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/16908071

1-2

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/16908071

168-172

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/16908071

A novel form of mastocytosis associated with a transmembrane c-kit mutation and response to imatinib

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.07.004

7 January 2021

c-Kit and c-kit mutations in mastocytosis and other hematological diseases.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.07.004

7 January 2021

Epidermal Langerhans cell-targeted gene expression by a dectin-2 promoter

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.07.004

7 January 2021

Incidence and prognosis of c-KIT and FLT3 mutations in core binding factor (CBF) acute myeloid leukaemias

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.07.004

7 January 2021

Activating mutations in the catalytic or juxtamembrane domain of c-kit in splenic mast cell tumors of cats.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.07.004

7 January 2021

Prevalence and importance of internal tandem duplications in exons 11 and 12 of c-kit in mast cell tumors of dogs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.07.004

7 January 2021

c-kit proto-oncogene exon 8 in-frame deletion plus insertion mutations in acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.07.004

7 January 2021

Mutations in KIT and RAS are frequent events in pediatric core-binding factor acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.07.004

7 January 2021

Novel germline mutation of KIT associated with familial gastrointestinal stromal tumors and mastocytosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.07.004

7 January 2021

Inhibition of KIT tyrosine kinase activity: a novel molecular approach to the treatment of KIT-positive malignancies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.07.004

7 January 2021

KIT exon 8 mutations associated with core-binding factor (CBF)-acute myeloid leukemia (AML) cause hyperactivation of the receptor in response to stem cell factor.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.07.004

7 January 2021

A phase I clinical trial evaluating imatinib mesylate (Gleevec) in tumor-bearing cats

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.07.004

7 January 2021

Classes of c-KIT activating mutations: proposed mechanisms of action and implications for disease classification and therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.07.004

7 January 2021

Clustering of activating mutations in c-KIT's juxtamembrane coding region in canine mast cell neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.07.004

7 January 2021

Mutations in the receptor tyrosine kinase pathway are associated with clinical outcome in patients with acute myeloblastic leukemia harboring t(8;21)(q22;q22).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.07.004

7 January 2021

Imatinib mesylate for refractory acute myeloblastic leukemia harboring inv(16) and a C-KIT exon 8 mutation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.07.004

7 January 2021

Growth factor receptor tyrosine kinases

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.07.004

7 January 2021

Mutations in the juxtamembrane domain of c-KIT are associated with higher grade mast cell tumors in dogs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.07.004

7 January 2021

Identifiers

10.1016/J.VETIMM.2006.07.004

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/16908071

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/16908071

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54587561&oldid=1584525002"